Resultados de la búsqueda

Benedicto I, Carmona RM, Barettino A, Espinós-Estévez C, Gonzalo P, Nevado RM, de la Fuente-Pérez M, Andrés-Manzano MJ, González-Gómez C, Rolas L, Dorado B, Nourshargh S, Hamczyk MR, Andrés V. Exacerbated atherosclerosis in progeria is prevented by progerin elimination in vascular smooth muscle cells but not endothelial cells. doi:10.1073/pnas.2400752121. Proc Natl Acad Sci U S A (2024) 121:e2400752121

Díez-Díez M, Amorós-Pérez M, de la Barrera J, Vázquez E, Quintas A, Pascual-Figal DA, Dopazo A, Sánchez-Cabo F, Kleinman ME, Gordon LB, Fuster V, Andrés V*, Fuster JJ* *co-corresponding authors Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome. doi: 10.1007/s11357-022-00607-2. Geroscience (2023) 45:1231-1236
Link to the full text in Repisalud

Andrés V, Díez J. Failing Hypertensive Heart: a Question of Altered Telomere Biology? Hypertension (2022) 79:2185-2187
Link to the full text in Repisalud

Macías Á, Díaz-Larrosa JJ, Blanco Y, Fanjul V, González-Gómez C, Gonzalo P, Andrés-Manzano MJ, da Rocha AM, Ponce-Balbuena D, Allan A, Filgueiras-Rama D, Jalife J, Andrés V Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome Cardiovasc Res (2022) 118:503-516
Link to the full text in Repisalud

Matesanz N, Viana-Huete V, Zuriaga MA, Zorita V, Ferrer-Perez A, Amoros-Perez M, Carriero R, Kunderfranco P, Greco CM, Fuster JJ. TP53-MUTANT CLONAL HEMATOPOIESIS ACCELERATES EXPERIMENTAL ATHEROSCLEROSIS DEVELOPMENT Atherosclerosis (2022) 355

Amoros-Perez M, Zorita V, Moro-Moro R, Matesanz N, Viana-Huete V, Ferrer-Perez A, Fuster JJ. NO EFFECT OF RADIATION-RELATED CLONAL HEMATOPOIESIS DRIVEN BY PPM1D MUTATIONS ON EXPERIMENTAL ATHEROSCLEROSIS DEVELOPMENT Atherosclerosis (2022) 355:E125-E125

Saez A, Gonzalez-Granado JM. Recent Advances in Intermediate Filaments-Volume 1 Int J Mol Sci (2022) 23

Andres, Vicente New Animal Models To Investigate Molecular And Cellular Mechanisms Of Cardiovascular Disease And Premature Aging In Hutchinson-Gildford Progeria Syndrome TISSUE ENG PART A (2022) 28:S18-S19

Benedicto I, Chen X, Bergo MO, Andrés V. Progeria: a perspective on potential drug targets and treatment strategies. EXPERT OPIN BIOL TH (2022) 26:393-399
Link to the full text in Repisalud

Chen X, Yao H, Andrés V, Bergo MO, Kashif M. Status of treatment strategies for Hutchinson-Gilford progeria syndrome with a focus on prelamin: A posttranslational modification. BASIC CLIN PHARMACOL (2022) 131:217-223
Link to the full text in Repisalud